论文部分内容阅读
Innovate drug discovery relies on the identification of new drug targets and lead compounds.However,traditional experimental methods hardly satisfy the demand for target identification and lead compound design processes during the drug discovery pipeline.Through a theoretical-simulation-driven strategy,we combined computational biology and experimental biology to conduct target identification,lead discovery and design and protein dynamic researches towards several important disease systems.